• Thumbnail

    Patient-centricity: Ghost in the machine

    In the complex machine of modern healthcare, until recently the patient has been a small cog. In this special in-depth feature, we ask stakeholders from across healthcare to share their insights on how engaging patients is transforming the industry

  • Thumbnail

    International Clinical Researcher of the Year 2016 winners revealed

    PharmaTimes Media recognised top clinical researchers with a spectacular awards ceremony at the Lancaster London last night.

  • Thumbnail

    Approvals round-up: 20 May

    This week's round-up of drug approvals and HTA news includes: an SMC recommendations for AbbVie's Humira; decentralised approval in five EU countries for Martindale's Prenoxad injection; and an EU thumbs up for BMS' Opdivo and Yervoy

  • Thumbnail

    90TEN boosts PR division

    New hires from Bisector 2 and Tonic

  • Thumbnail

    Havas Lynx EU - Making patients smile

    Research has linked improved wellbeing with a wide-range of health benefits, including better cancer outcomes, lower risk of heart disease and stroke, and stronger immune and endocrine systems.

News

View all
Thumbnail

EU lifts neuropsychiatric warning for Pfizer’s Champix

European regulators have removed the black triangle warning from the label of Pfizer's smoking cessation drug Champix, on the back of data from a post-marketing surveillance study backing its neuropsychiatric safety.

24th May 2016

Thumbnail

Patient-centricity: Ghost in the machine

In the complex machine of modern healthcare, until recently the patient has been a small cog. In this special in-depth feature, we ask stakeholders from across healthcare to share their insights on how engaging patients is transforming the industry

Thumbnail

Patient-centricity: The lifecycle

Continuing our in-depth coverage of patient-centricity, we look at how companies are listening to the patient voice at each stage of a drug's life cycle

Thumbnail

SmartViews: The price of success

Pharma has struggled with the dilemma of drug pricing and patent enforcement in developing countries for decades but recent developments suggest the industry may take a new route, write Leo Neels and Walter Van Dyck

Thumbnail

SmartViews: Patents unprotected

In light of the announcement of GSK's IP scaleback in developing countries, Simon Cohen asks whether this new approach will improve access to medicines for the world's poorest

Thumbnail

SmartViews: Barriers to change

Moves towards greater patient-centricity are beset by barriers, but with empowered patients eager to engage, the incentive to act has never been greater, argues Ana Nicholls

Thumbnail

SmartView: Cold case

Moving medicines from plant to patients has never been more challenging but innovations in temperature-controlled packaging are helping cut cold chain risks, writes Kevin Lawler

Thumbnail

SmartPeople: The ride of your life

In June, 300 melanoma stakeholders will meet to discuss ways to improve patient care – but what marks this ordinary-sounding event out is that 200 attendees have the disease themselves and it is being entirely organised by a single patient

Appointments

View all

Download our apps

Goto the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Goto the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Download